Abstract
Cancer is the second most common cause of death during the reproductive years, complicating approximately 1/1000 pregnancies. The occurrence of cancer during gestation is likely to increase as a result of a woman's tendency to delay childbearing. Improved diagnostic techniques for malignancies increases detection of cancer during pregnancy. Malignant conditions during gestation are believed to be associated with an increase in poor perinatal and fetal outcomes that are often due to maternal treatment. Physicians should weigh the benefits of treatment against the risks of fetal exposure. To date, most reports have focused on morphologic observations made very close to the time of delivery with little data collected on children's long-term neurodevelopment following in utero exposure to malignancy and treatment. Because the brain differentiates throughout pregnancy and in early postnatal life, damage may occur even after first trimester exposure. The possible delayed effects of treatment on a child's neurological, intellectual and behavioural functioning have never been systematically evaluated. The goal of this report was to summarize all related issues into one review to facilitate both practitioners’ and patients’ access to known data on fetal risks and safety. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Angelucci L, Patacchioli FR, Scaccianoce S, Di Sciull A, Maccari S and Cardillo A (1985) A model for later-life effects of perinatal drug exposure: Maternal hormone mediation. Neurobehav Toxicol Teratol 7: 511–517
Anonymous (1995) Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 273: 413–418
Aviles A and Niz J (1988) Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 16: 3–6
Aviles A, Zepeda G and Cruz J (1991) Hodgkin's disease during pregnancy. Study of late effects in the newborn. Bol Med Hosp Infant Mex 48: 622–626
Baisogolov GD and Shishkin IP (1985) Course of pregnancy and condition of infants born to patients treated for lymphogranulomatosis [Russian]. Med Radiol (Mosk) 30: 35–37
Balcewicz-Sablinska K, Ciesluk S, Kopec I, Slomkowski M and Maj S (1990) Analysis of pregnancy, labor, child development and disease course in women with Hodgkin's disease. Acta Haematol Pol 21: 72–80
Blatt J, Mulvihill JJ, Ziegler JL, Yong RC and Poplack DG (1980) Pregnancy outcome following cancer chemotherapy. Am J Med 69: 828–832
Brent RL (1980) Radiation teratogenesis. Teratology 21: 281–298
Brown JE, Jacobson HN, Askue LH and Peick MG (1981) Influence of pregnancy weight gain on the size of infants born to underweight women. Obstet Gynecol 57: 13–17
Caligiuri MA and Mayer RJ (1989) Pregnancy and Leukemia. Semin Oncol 16: 388–396
Cantini E and Yanes B (1984) Acute myelogenous leukemia in pregnancy. South Med J 77: 1050–1052
Chambers CD, Johnson KA, Dick LM, Felix RJ and Jones KL (1998) Maternal fever and birth outcome: a prospective study. Teratology 58: 251–257
Clarren SK, Smith DW, Harvey MA and Ward KH (1979) Hyperthermia: a prospective evaluation of a possible teratogenic agent in man. J Pediatr 95: 81–83
Collaborative Group on Antenatal Steroid Therapy (1984) Effects of antenatal dexamethasone administration in the infant: long-term follow-up. J Pediatr 104: 259–267
Dekaban AS (1968) Abnormalities in children exposed to x-radiation during various stages of gestation: tentative timetable of radiation injury to the human fetus. J Nucl Med 9: 412–477
Doll DC, Ringenberg QS and Yarbo JW (1988) Management of cancer during pregnancy. Arch Intern Med 148: 2058–2064
French NP, Hagan R, Evans SF, Godfrey MRN and Newnham J (1999) Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 180: 114–121
Friedman JM (1988) Teratogen update: anesthetic agents. Teratology 37: 69–77
Gililland J and Weinstein L (1983) The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv 38: 6–13
Granoth G (1979) Defects of the central nervous system in Finland. IV Associations with diagnostic X-ray examinations. Am J Obstet Gynecol 133: 191–194
Harada M (1978) Congenital Minamata disease: intrauterine methylmercury poisoning. Teratology 18: 285–288
Hoel DG (1987) Radiation risk estimation models. Environ Health Perspect 75: 105–107
Jensh RP and Brent RL (1986) Effects of 0.6-Gy prenatal X irradiation on postnatal neurophysiologic development in the Wistar rat. Proc Soc Exp Biol Med 181: 611–619
Jensh RP and Brent RL (1987) The effect of low level prenatal X-irradiation on postnatal development in the Wistar rat. Proc Soc Exp Biol Med 184: 256–263
Kallen B and Mazze RI (1990) Neural tube defects and first trimester operations. Teratology 41: 717–720
Konopka P, Raymond JP, Merceron RE and Seneze J (1983) Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 146: 935–938
Koren G and Nulman I (1994) Teratogenic Drugs and Chemicals in Humans. In: Maternal Fetal Toxicology: Clinician's Guide, 2nd edn, Koren G (ed.) pp 33–48, Marcel Dekker: New York
Kozlowski RD, Steinbrunner JV and MacKenzie AH (1990) Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 88: 589–592
Layde PM, Edmonds LD and Erickson JD (1980) Maternal fever and neural tube defects. Teratology 21: 105–108
MacArthur BA, Howie RN, Dezoete JA and Elkins J (1982) School progress and cognitive development of 6-year old children whose mothers were treated antenatally with betamethasone. Pediatrics 70: 99–105
Meaney MJ, Stewart J and Beatty WW (1982) The influence of glucocorticoids during the neonatal period on the development of play-fighting in Norway rat pups. Horm Behav 16: 475–491
Medkova J (1991) Analysis of the health condition of the children born to the personnel exposed to cytostatics at an oncology unit. Acta Univ Palacki Olomuc Fac Med 130: 323–332
Metcoff J, Costiloe JP, Crosby W, Bentle L, Seshachalam D, Sandstead HH, Bodwell CE, Weaver F and McClain P (1981) Maternal nutrition and fetal outcome. Am J Clin Nutr 34: 708–721, (Suppl 4)
Mettler FA and Moseley RD (1985). Medical Effects of Ionizing Radiation, 206–209, Grune & Stratton: New York
Meyer MB and Tonascia J (1981) Long term effects of prenatal x-ray of human females. Am J Epidemiol 114: 317–326
Miller P, Smith DW and Shepard TH (1978) Maternal hyperthermia as a possible cause for anencephaly. Lancet 1: 519–521
Nader S (1990) Pituitary disorders and pregnancy. Semin Perinatol 14: 24–33
Naeye RL and Chez RA (1981) Effects of maternal acetonuria and low pregnancy weight gain on children's psychomotor development. Am J Obstet Gynecol 139: 189–193
Odom LD, Plouffe L and Butler WJ (1990) 5-Fluorouracil exposure during the period of conception: Report on two cases. Am J Obstet Gynecol 163: 76–77
Otake M and Schull WJ (1984) In utero exposure to A-bomb radiation and mental retardation: a reassessment. Br J Radiol 57: 409–414
Potter JF and Schoeneman M (1970) Metastasis of maternal cancer to the placenta and fetus. Cancer 25: 380–388
Pritchard JA, MacDonald PC and Gant NF (1985). Williams Obstetrics, 17th edn, Appleton-Century-Crofts: Norwalk, CT
Reynoso EE, Sheperd FA, Messner HA, Farquharson HA, Garvey MB and Baker MA (1987) Acute leukemia during pregnancy: the Toronto Leukemia Study group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 5: 1098–1106
Schardein JL (1985) Cancer chemotherapeutic agents. In: Chemically Induced Birth Defects, Schardein JL (ed.) pp 467 Marcel Dekker: NY and Basel
Schull WJ, Norton S and Jensh RP (1990) Ionizing radiation and the developing brain. Neurotoxicol Teratol 12: 249–260
Stein Z, Susser M, Saenger G and Marolla F (1972) Nutrition and mental performance. Science 178: 708–713
Sylvester GC, Khoury MJ, Lu X and Erickson D (1994) First-trimester anesthesia exposure and the risk of central nervous system defects: A population-based case-control study. Am J Public Health 84: 1757–1760
Tincani A, Faden D, Tarantini M, Lojacono A, Tanzi P, Gastaldi A, Di Mario C, Spatola L, Cattaneo R and Balestrieri G (1992) SLE and pregnancy: a prospective study. Clin Exp Rheumatol 10: 439–446
Trautman PD, Meyer-Bahlburg HF, Postelnek J and New MI (1995) Effects of early prenatal dexamethasone on the cognitive and behavioral development of young children: results of a pilot study. Psychoneuroendocrinology 20: 439–449
Turkalj I, Braun P and Krupp P (1982) Surveillance of bromocriptine in pregnancy. JAMA 247: 1589–1591
US Department of Health and Human Services Vital Statistics of the Unites Stat. (1976). Bol. Natality, Hyattsville, MD, National Center for Health Statistics 1980
Veszelovszky I, Farkasinszky T, Nogy J, Bodis L and Szilard J (1981) Psychological and neurosomatic follow-up studies of children of mother treated with dexamethasone. Orv Hetil 122: 629–631
Vorhees CV (1986) Principles of behavioural teratology. In: Handbook of Behavioural Teratology, Riley EP, Vorhees CV (eds) pp 23–48, Plenum Press: New York
Wagoner LE, Taylor DO, Olsen SL, Price GD, Rasmussen LG, Larsen CB, Scott JR and Renlund DG (1994) Immunosuppressive therapy, management, and outcome of heart transplant recipients during pregnancy. J Heart Lung Transplant 12: 993–1000
Webster WS, Lipson AH and Sulik KK (1988) Interference with gastrulation during the third week of pregnancy as a cause of some facial abnormalities and CNS defects. Am J Med Genet 31: 505–512
Woo SY, Fuller LM, Cundiff JH, Bondy ML, Hagemeister FB, McLanghlin P, Velasquez WS, Swan F, Rodriguez MA and Cabanillas F (1992) Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease. Int J Radiat Oncol Biol Phys 23: 407–412
Yoshimaru H, Otake M, Fujikoshi Y and Schull WJ (1991) Effect on school performance of prenatal exposure to Hiroshima atomic bomb. Nippon Eiseigaku Zasshi 46: 747–754
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Nulman, I., Laslo, D., Fried, S. et al. Neurodevelopment of children exposed in utero to treatment of maternal malignancy. Br J Cancer 85, 1611–1618 (2001). https://doi.org/10.1054/bjoc.2001.2090
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2090
Keywords
This article is cited by
-
Schwangerschaft und Mammakarzinom – was sind die Besonderheiten bei Diagnostik und Therapie?
Die Gynäkologie (2023)
-
Das Mammakarzinom in der Schwangerschaft
best practice onkologie (2019)
-
Acute myeloid leukemia and pregnancy: clinical experience from a single center and a review of the literature
BMC Cancer (2017)
-
Das Mammakarzinom in der Schwangerschaft
Der Gynäkologe (2017)